High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer
Phase 2 Suspended
36 enrolled
The Impact of Surgeon-Interpreted Intraoperative Margin Assessment During Breast Conserving Surgery on Postoperative Treatment
Suspended
175 enrolled
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
Suspended
2,400 enrolled
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
Phase 1 Suspended
42 enrolled
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)
Phase 2 Suspended
98 enrolled
Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer
Suspended
15 enrolled
Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer
Suspended
300 enrolled
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Suspended
22 enrolled
Fluzoparib in Combination With or Without Camrelizumab for Homologous Recombinant Deficiency (HRD) HER2 Negative Advanced Breast Cancer
Phase 2 Suspended
80 enrolled
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer
Phase 2/3 Suspended
928 enrolled
Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer
Phase NA Suspended
350 enrolled
LoTam
Phase 3 Suspended
1,156 enrolled
Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)
Phase NA Suspended
5,200 enrolled
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Phase 1/2 Suspended
29 enrolled
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
Phase 1 Suspended
20 enrolled
Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca
Phase 2 Suspended
48 enrolled
CRYOMATASE
Phase NA Suspended
70 enrolled
Pilot Trial of Preop Partial Radiation in Breast Cancer Patients
Phase 1 Suspended
98 enrolled
Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy
Suspended
500 enrolled
A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
Phase 1 Suspended
131 enrolled
MIRROR
Suspended
20 enrolled
Physiotherapy Program Impact on Breast Cancer-Related Lymphedema
Phase NA Suspended
21 enrolled
Adherence Intervention in Patients With Metastatic Breast Cancer
Phase NA Suspended
35 enrolled
Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring
Suspended
150 enrolled
IPT
Phase 3 Suspended
20 enrolled
Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)
Phase 2 Suspended
61 enrolled
Postoperative Identification of Tumor Cells At the Lumpectomy Site of Patients with Early Breast Cancer
Phase NA Suspended
20 enrolled
RNSM
Phase NA Suspended
30 enrolled
Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment
Suspended
10 enrolled
IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors
Phase 1 Suspended
135 enrolled
Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer
Phase 3 Suspended
201 enrolled 19 charts
A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer
Phase 1/2 Suspended
65 enrolled
Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer
Phase 1 Suspended
24 enrolled
Diffusion-Weighted MRI for Breast Cancer Screening in Women With a Personal History of Breast Cancer
Suspended
1,694 enrolled
DNX-2440 for Resectable Colorectal Liver Metastasis
Phase 1 Suspended
30 enrolled
DIRECT-2
Phase 3 Suspended
10 enrolled
A Trial Evaluating the Efficacy and Safety of EndoTAGĀ®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer
Phase 3 Suspended
420 enrolled
Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors
Phase 1 Suspended
220 enrolled
Guangzhou Women's Health Cohort Study (GWHCS)
Suspended
1,000,000 enrolled
Comparison of Two Types of Biopsy in Suspicious Axillary Lymph Nodes
Phase NA Suspended
135 enrolled
A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
Phase 1 Suspended
21 enrolled
Short and Long Term Effects of a Physical Therapy Program After Breast Cancer Surgery
Phase NA Suspended
36 enrolled
Understanding Patient Experience and Preferences for the QT Scanner Compared to Mammography
Suspended
20 enrolled
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer
Phase 2 Suspended
170 enrolled
Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics
Phase NA Suspended
100 enrolled
Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile
Suspended
20 enrolled
Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer
Phase 2 Suspended
250 enrolled
Guide for Prioritisation of Patients for Referral to Breast Clinics
Suspended
4,000 enrolled
Clinical Evaluation of Opto-Acoustic Image Quality With the Gen1B Duplex Probe in Breast Applications
Phase NA Suspended
4 enrolled
A Study of First-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBC
Phase 3 Suspended
375 enrolled